Inovio Pharmaceuticals

Inovio Pharmaceuticals just entered Phase 1 of clinical trials for its COVID-19 vaccine. In this phase, the immunogenicity and safety are being tested on 40 subjects who are healthy volunteers.

A crop of life sciences companies are rushing to combat the coronavirus, and part of that race is playing out among biotech businesses based in San Diego.

A San Diego biotech company just received a $9 million grant to develop a vaccine for the coronavirus. Inovio Pharmaceuticals received a grant from the Coalition for Epidemic Preparedness Innovations (CEPI). The grant builds on Inovio’s existing partnership with CEPI, in which the company was granted in April 2018 an award of up to $56 million to develop vaccines for…